IP Verse

Kraus patent opposition analysis

The comprehensive analysis of Kraus opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Kraus

Stay updated with the latest patent oppositions filed by Kraus

Patent NumberTitleApplicantOpposition DateOpposition Company
EP3539540
Pharmaceutical Composition, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIMSep 12, 2025TEVA PHARMACEUTICALS
EP3321270
Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5] Pyrazino [2, 1-B] Oxazepin-8-OlateGILEAD SCIENCESSep 3, 2025KRAUS & LEDERER PARTGMBB
EP3135287
Preparation Containing Tetracyclic Compound At High DoseCHUGAI SEIYAKU KABUSHIKI KAISHAAug 19, 2025TEVA PHARMACEUTICALS
EP4072301
Nanoemulsion For Oral UseNICOVENTURESAug 5, 2025DSM ASSETS
EP3784283
Cannabidiol Preparations And Its UsesJAZZ PHARMACEUTICALS RESEARCH UKJul 23, 2025KRAUS & LEDERER PARTGMBB
EP3242666
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSJul 15, 2025SANDOZ
EP3710058
Use Of Cannabinoids In The Treatment Of Seizures Associated With Lennox-Gastaut SyndromeGW RESEARCHJul 8, 2025KRAUS & LEDERER PARTGMBB
EP3706739
Use Of Riluzole Prodrugs To Treat AtaxiasBIOHAVEN THERAPEUTICSJul 2, 2025KRAUS & LEDERER PARTGMBB
EP4174150
Method Of Treating Waste PlasticNESTE OYJJun 23, 2025KRAUS & LEDERER PARTGMBB
EP3882275
Anti-Pd-1 And Anti-Vegfa Bifunctional Antibody, Pharmaceutical Composition Thereof And Use ThereofAKESO BIOPHARMAJun 18, 2025STRAWMAN

Top clients of Kraus

Top companies who are the clients of Kraus

CompanyTotal
KRAUS & LEDERER PARTGMBB63
TEVA PHARMACEUTICALS27
SANDOZ26
DSM NUTRITIONAL PRODUCTS16
HEXAL6
STADA ARZNEIMITTEL4
ALFASIGMA4
LUYE PHARMA SWITZERLAND3
SANOVEL IIAC SAN VE TIC3
DSM ASSETS3